A detailed history of Exane Derivatives transactions in Phreesia, Inc. stock. As of the latest transaction made, Exane Derivatives holds 20 shares of PHR stock, worth $369. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Previous 20 -0.0%
Holding current value
$369
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 22, 2022

SELL
$23.5 - $42.96 $14,899 - $27,236
-634 Reduced 96.94%
20 $0
Q4 2021

Jan 28, 2022

BUY
$39.92 - $74.89 $25,668 - $48,154
643 Added 5845.45%
654 $27,000
Q1 2021

Apr 30, 2021

SELL
$50.85 - $80.61 $9,864 - $15,638
-194 Reduced 94.63%
11 $0
Q4 2020

Jan 27, 2021

SELL
$30.74 - $57.9 $88,039 - $165,825
-2,864 Reduced 93.32%
205 $11,000
Q3 2020

Oct 06, 2020

BUY
$27.0 - $33.05 $82,863 - $101,430
3,069 New
3,069 $98,000

Others Institutions Holding PHR

About Phreesia, Inc.


  • Ticker PHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 52,532,200
  • Market Cap $970M
  • Description
  • Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a ra...
More about PHR
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.